Protein Variants | Comment | Organism |
---|---|---|
additional information | selectively depletion by siRNA of NMT1 and/or NMT2 from HEK-293T cells expressing a recombinant NefsgGFP fusion protein, NMT1 depletion has minimal effect on the intracellular distribution of Nef-sgGFP, whereas depletion of NMT2 alters distribution to a diffuse, widespread pattern, mimicking that of a myristoylation-deficient mutant of Nef-sgGFP, overview | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
HIV1 Nef protein N-terminal peptide | Nef peptide acts as a competitive inhibitor for the myristoylation of Gag; Nef peptide acts as a competitive inhibitor for the myristoylation of Gag | Homo sapiens |
KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
additional information | - |
additional information | NMT1 and NMT2 have 30 and 130fold lower Km values for Nef than Gag, respectively. Michaelis-Menten kinetics, and kinetic modelling of isozymes, overview | Homo sapiens | |
0.0015 | - |
HIV1 Nef protein N-terminal peptide | pH 7.4, 37°C, isozyme NMT2 | Homo sapiens | |
0.011 | - |
HIV1 Nef protein N-terminal peptide | pH 7.4, 37°C, isozyme NMT1 | Homo sapiens | |
0.196 | - |
HIV1 Gag protein N-terminal peptide | pH 7.4, 37°C, isozyme NMT2 | Homo sapiens | |
0.33 | - |
HIV1 Gag protein N-terminal peptide | pH 7.4, 37°C, isozyme NMT1 | Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
tetradecanoyl-CoA + glycyl-HIV1 Gag protein N-terminal peptide | Homo sapiens | - |
CoA + N-tetradecanoyl-glycyl-HIV1 Gag protein N-terminal peptide | - |
? | |
tetradecanoyl-CoA + glycyl-HIV1 Nef protein N-terminal peptide | Homo sapiens | - |
CoA + N-tetradecanoyl-glycyl-HIV1 Nef protein N-terminal peptide | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | O60551 | isozyme NMT2; isozyme NMT2 | - |
Homo sapiens | P30419 | isozyme NMT1; isozyme NMT1 | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | N-myristoyltransferase isozymes exhibit differential specificity for human immunodeficiency virus type 1 Gag and Nef, overview | Homo sapiens | ? | - |
? | |
myristoyl-CoA + HIV1 Gag protein N-terminal peptide | - |
Homo sapiens | N-myristoyl-HIV1 Gag protein N-terminal peptide + CoA | - |
? | |
myristoyl-CoA + HIV1 Nef protein N-terminal peptide | - |
Homo sapiens | N-myristoyl-HIV1 Nef protein N-terminal peptide + CoA | - |
? | |
tetradecanoyl-CoA + glycyl-HIV1 Gag protein N-terminal peptide | - |
Homo sapiens | CoA + N-tetradecanoyl-glycyl-HIV1 Gag protein N-terminal peptide | - |
? | |
tetradecanoyl-CoA + glycyl-HIV1 Gag protein N-terminal peptide | i.e. myristoyl-CoA | Homo sapiens | CoA + N-tetradecanoyl-glycyl-HIV1 Gag protein N-terminal peptide | - |
? | |
tetradecanoyl-CoA + glycyl-HIV1 Nef protein N-terminal peptide | - |
Homo sapiens | CoA + N-tetradecanoyl-glycyl-HIV1 Nef protein N-terminal peptide | - |
? | |
tetradecanoyl-CoA + glycyl-HIV1 Nef protein N-terminal peptide | i.e. myristoyl-CoA, NMT2 has approximately 5fold higher catalytic efficiency for the myristoylation of Nef than NMT1 | Homo sapiens | CoA + N-tetradecanoyl-glycyl-HIV1 Nef protein N-terminal peptide | - |
? |
Synonyms | Comment | Organism |
---|---|---|
N-myristoyltransferase | - |
Homo sapiens |
NMT | - |
Homo sapiens |
NMT1 | - |
Homo sapiens |
NMT2 | - |
Homo sapiens |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
37 | - |
assay at | Homo sapiens |
Turnover Number Minimum [1/s] | Turnover Number Maximum [1/s] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.032 | - |
HIV1 Nef protein N-terminal peptide | pH 7.4, 37°C, isozyme NMT2 | Homo sapiens | |
0.052 | - |
HIV1 Nef protein N-terminal peptide | pH 7.4, 37°C, isozyme NMT1 | Homo sapiens | |
0.107 | - |
HIV1 Gag protein N-terminal peptide | pH 7.4, 37°C, isozyme NMT2 | Homo sapiens | |
0.265 | - |
HIV1 Gag protein N-terminal peptide | pH 7.4, 37°C, isozyme NMT1 | Homo sapiens |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
7.4 | - |
assay at | Homo sapiens |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
additional information | - |
additional information | competitive inhibition kinetics of HIV1 Gag and Nef protein N-terminal peptides, overview | Homo sapiens |
kcat/KM Value [1/mMs-1] | kcat/KM Value Maximum [1/mMs-1] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.98 | - |
HIV1 Gag protein N-terminal peptide | pH 7.4, 37°C, isozyme NMT2 | Homo sapiens | |
1 | - |
HIV1 Gag protein N-terminal peptide | pH 7.4, 37°C, isozyme NMT1 | Homo sapiens | |
4.9 | - |
HIV1 Nef protein N-terminal peptide | pH 7.4, 37°C, isozyme NMT1 | Homo sapiens | |
23.6 | - |
HIV1 Nef protein N-terminal peptide | pH 7.4, 37°C, isozyme NMT2 | Homo sapiens |